ALNADERM
ActiveALNADERM has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €19k and a net result of €70k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 16% of 16459 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
74
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency39▼-1
Growth32=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1k at 30 days acceptable
Liquidity short (current ratio 0.9 against 0.79 in 2024; short-term debt: 86.1% and cash: 66.5% of total assets), and 86.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
13.9%
Return on assets
52.3%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 16459 sector peers (2025).
NBB · sector comparisonPosition among 16459 sector peers
Solvency
better than 16%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-03-2026, 133 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
133 d early
2024
37 d early
2023
71 d early
2022
80 d early
2021
59 d early
2020
31 d late
2019
34 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
18-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€19k▲ 0.3%
2024 · €19k
2019: €104k
2020: €155k
2021: €218k
2022: €12k
2023: €19k
2024: €19k
2019 → 2025
Total assets
€134k▲ 6.2%
2024 · €126k
2019: €153k
2020: €176k
2021: €240k
2022: €284k
2023: €155k
2024: €126k
2019 → 2025
Net result
€70k▼ 9.5%
2024 · €77k
2019: €93k
2020: €51k
2021: €63k
2022: €48k
2023: €69k
2024: €77k
2019 → 2025
Working capital
€-11k▲ 46.1%
2024 · €-21k
2019: €75k
2020: €119k
2021: €190k
2022: €-54k
2023: €-34k
2024: €-21k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€218k-€12k▼ 94.3%€19k▲ 50.0%€19k=€19k▲ 0.3%
Operating result€80k-€64k▼ 19.9%€92k▲ 43.9%€103k▲ 12.4%€94k▼ 9.3%
Net result€63k-€48k▼ 23.6%€69k▲ 42.0%€77k▲ 12.6%€70k▼ 9.5%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 9% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €134k
Fixed assets
€30k▼ 34.4%
Current assets
€104k▲ 29.3%
Equity and liabilities €134k
Equity
€19k▲ 0.3%
Debt
€115k▲ 7.2%
The debt ratio rises from 85.3% to 86.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€111k▼
2024 · €120k
Cash flow
€87k▼
2024 · €94k
Solvency
13.9%▼
2024 · 14.7%
Current ratio
0.90▲
2024 · 0.79
Quick ratio
0.90▲
2024 · 0.79
Debt / equity
6.18▲
2024 · 5.79
ROE
375.5%▼
2024 · 416.4%
ROA
52.3%▼
2024 · 61.4%
Interest coverage
801.65▼
2024 · 965.79
Debt
€115k▲
2024 · €108k
Debt ≤ 1 year
€115k▲
2024 · €102k
Income taxes
€24k▼
2024 · €26k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€126k€134k▲
Fixed assets21/28€46k€30k▼
Tangible fixed assets22/27€46k€30k▼
Plant, machinery and equipment23€3k€2k▼
Furniture and vehicles24€23k€15k▼
Other tangible fixed assets26€20k€14k▼
Current assets29/58€80k€104k▲
Amounts receivable within one year40/41€4k€6k▲
Trade receivables40-€2k
Other amounts receivable41€4k€3k▼
Cash at bank and in hand54/58€70k€89k▲
Deferred charges and accrued income490/1€7k€9k▲
Equity and liabilities
Total equity and liabilities10/49€126k€134k▲
Equity10/15€19k€19k▲
Contributions10/11€19k€19k=
Reserves13-€57
Distributable reserves133-€57
Amounts payable17/49€108k€115k▲
Amounts payable within one year42/48€102k€115k▲
Trade debts44€982€7k▲
Suppliers440/4€982€7k▲
Taxes, remuneration and social security45€12k-
Taxes450/3€12k-
Other amounts payable47/48€89k€108k▲
Accrued charges and deferred income492/3€6k-
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€17k€17k▼
Other operating charges640/8-€871
Gross operating margin9900€120k€112k▼
Operating profit (loss)9901€103k€94k▼
Financial income75/76B-€1
Recurring financial income75-€1
Financial charges65/66B€125€138▲
Recurring financial charges65€125€138▲
Profit (loss) for the period before taxes9903€103k€94k▼
Income taxes67/77€26k€24k▼
Profit (loss) for the period9904€77k€70k▼
Profit (loss) for the period to be appropriated9905€77k€70k▼
Appropriation of the result
Profit (loss) to be appropriated9906€77k€70k▼
Transfer to equity691/2-€57
To other reserves6921-€57
Profit to be distributed694/7€77k€70k▼
Return on contributions (dividend)694€77k€70k▼
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
20-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
24-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
21-05
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
12-05
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Weakest financial yearnet €48k ▼23.6%
Net result drops to €48k, the lowest in the series; recovery starts the following year.
02-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Equity above €200kEq €218k ▲40.4%
3 profitable years in a row build equity to €218k.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
31-12
Financial
Liquidity triplescurrent ratio 6.63
Current ratio from 2.53 to 6.63; short-term debt falls from €49k to €21k.
31-12
Financial
Equity above €150kEq €155k ▲48.4%
2 profitable years in a row build equity to €155k.
03-09
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 34 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Leuven · 2 establishment units since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Sneppenstraat 1263010 LeuvenGround area
9,145 m²
Building footprint
422 m²
Volume, LiDAR
2,278 m³
2 parcels, Flanders · tallest building 19.6 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
Sneppenstraat 126, 3010 Leuven
since 20182.285.138.371
Pastoor Eeckelaerslaan 1, 3010 Leuven
since 20212.319.414.015
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24051B0137/00K000 | Flanders | 8,479 m² | 1 · 270 m² | 19.6 m |
| 24482F0194/00P010 | Flanders | 666 m² | 1 · 152 m² | 9.3 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. Joke De Buck
BE 0713.517.251
Antwerpen · Eq €19k
DOCTEUR HAVAUX LAURENCE
BE 0716.633.129
Sint-Agatha-Berchem · Eq €19k
MED COSTE NEUPREZ
BE 0649.790.033
Liège · Eq €19k
DOCTEUR ELISE POZZA, OPHTALMOLOGUE
BE 0721.930.517
Tournai · Eq €19k
QUERTON ENDOCRINOLOGIE
BE 0552.710.057
Profondeville · Eq €19k
Of 16,623 companies in sector 86220 we hold annual accounts for 7,972. 3,056 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded28-12-2018
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
77225Rental and leasing activities
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.